NFAT targets signaling molecules to gene promoters in pancreatic β-cells

Molecular Endocrinology

Volumn 29, Issue 2, 2015, Pages 274-288

  Lawrence, Michael C ^a   Borenstein Auerbach, Nofit ^a   McGlynn, Kathleen ^b   Kunnathodi, Faisal ^a   Shahbazov, Rauf ^a   Syed, Ilham ^a   Kanak, Mazhar ^c   Takita, Morihito ^a   Levy, Marlon F ^d   Naziruddin, Bashoo ^d  

^a BAYLOR RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c BAYLOR UNIVERSITY   (United States)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; DNA; E1A ASSOCIATED P300 PROTEIN; EP300 PROTEIN, MOUSE; INSULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BINDING; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; DNA BINDING; DNA PROTEIN COMPLEX; DNA SYNTHESIS; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE TARGETING; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INSULIN RELEASE; MOUSE; NONHUMAN; NUCLEAR IMPORT; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROMOTER REGION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE CULTURE; ANIMAL; BIOLOGICAL MODEL; CELL SURVIVAL; DRUG EFFECTS; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROTEIN STABILITY; PROTEIN TRANSPORT; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; DNA; E1A-ASSOCIATED P300 PROTEIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HISTONE DEACETYLASES; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; NFATC TRANSCRIPTION FACTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TRANSPORT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TACROLIMUS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922277623     PISSN: 08888809     EISSN: 19449917     Source Type: Journal    
DOI: 10.1210/me.2014-1066     Document Type: Article

References (42)

1. Frankel BJ, Atwater I, Grodsky GM. Calcium affects insulin release and membrane potential in islet β-cells. Am J Physiol. 1981;240(1): C64–C72.
2. Weir GC, Mojsov S, Hendrick GK, Habener JF. Glucagonlike peptide I (7–37) actions on endocrine pancreas. Diabetes. 1989;38(3): 338–342.
3. Henquin JC, Dufrane D, Nenquin M. Nutrient control of insulin secretion in isolated normal human islets. Diabetes. 2006;55(12): 3470–3477.
4. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes. 2000;49(11):1751–1760.
5. Lu M, Wheeler MB, Leng XH, Boyd AE III. The role of the free cytosolic calcium level in β-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7–37). Endocrinology. 1993;132(1):94–100.
6. Holz GG IV, Leech CA, Habener JF. Activation of a cAMP-regulated Ca(2+)-signaling pathway in pancreatic β -cells by the insulinotropic hormone glucagon-like peptide-1. J Biol Chem. 1995; 270(30):17749–17757.
7. Gromada J, Dissing S, Bokvist K, et al. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting β TC3-cells by enhancement of intracellular calcium mobilization. Diabetes. 1995; 44(7):767–774.
8. Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Invest. 2007;117(1):24–32.
9. Lawrence MC, Bhatt HS, Watterson JM, Easom RA. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol Endocrinol. 2001;15(10):1758–1767.
10. Lawrence MC, Bhatt HS, Easom RA. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes. 2002;51(3):691–698.
11. Lawrence MC, McGlynn K, Park BH, Cobb MH. ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J Biol Chem. 2005;280(29):26751–26759.
12. Heit JJ, Apelqvist AA, Gu X, et al. Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function. Nature. 2006; 443(7109):345–349.
13. Soleimanpour SA, Crutchlow MF, Ferrari AM, et al. Calcineurin signaling regulates human islet β-cell survival. J Biol Chem. 2010; 285(51):40050–40059.
14. Demozay D, Tsunekawa S, Briaud I, Shah R, Rhodes CJ. Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2 -dependent calcineurin/NFAT signaling in primary pancreatic islet β-cells. Diabetes. 2011;60(11):2892–2902.
15. Goodyer WR, Gu X, Liu Y, Bottino R, Crabtree GR, Kim SK. Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT. Dev Cell. 2012;23(1):21–34.
16. Al-Uzri A, Stablein DM, A Cohn R. Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation. 2001;72(6):1020–1024.
17. Maes BD, Kuypers D, Messiaen T, et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation. 2001;72(10): 1655–1661.
18. Choi D, Kim BH, Lee MK, Cho H. Effects of water-soluble tacrolimus- PEG conjugate on insulin-dependent diabetes mellitus and systemic lupus erythematosus. Arch Pharm Res. 2011;34(8):1301–1310.
19. Maedler K, Sergeev P, Ris F, et al. Glucose-induced β cell production of IL-1 β contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 2002;110(6):851–860.
20. Böni-Schnetzler M, Thorne J, Parnaud G, et al. Increased interleukin (IL)-1 β messenger ribonucleic acid expression in β -cells of individuals with type 2 diabetes and regulation of IL-1 β in human islets by glucose and autostimulation. J Clin Endocrinol Metab. 2008;93(10):4065–4074.
21. Lawrence MC, Naziruddin B, Levy MF, Jackson A, McGlynn K. Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF- β gene expression in pancreatic islet endocrine cells. J Biol Chem. 2011;286(2):1025–1036.
22. Rabinovitch A. An update on cytokines in the pathogenesis of insulin- dependent diabetes mellitus. Diabetes Metab Rev. 1998; 14(2):129–151.
23. Piemonti L, Leone BE, Nano R, et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes. 2002;51(1):55–65.
24. Wachlin G, Augstein P, Schröder D, et al. IL-1 β, IFN- β and TNF- β increase vulnerability of pancreatic β cells to autoimmune destruction. J Autoimmun. 2003;20(4):303–312.
25. Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, Kalofoutis A. Inflammatory process in type 2 diabetes: the role of cytokines. Ann NY Acad Sci. 2006;1084:89–117.
26. Schwarznau A, Hanson MS, Sperger JM, et al. IL-1 β receptor blockade protects islets against pro-inflammatory cytokine induced necrosis and apoptosis. J Cell Physiol. 2009;220(2):341–347.
27. Zineh I, Beitelshees AL, Silverstein JH, Haller MJ. Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetes. Diabetes Care. 2009;32(3):465–467.
28. McCall M, Pawlick R, Kin T, Shapiro AM. Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice. Am J Transplant. 2012;12(2):322–329.
29. Panee J. Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes. Cytokine. 2012;60(1):1–12.
30. Zaitsev SV, Appelskog IB, Kapelioukh IL, et al. Imidazoline compounds protect against interleukin 1 β -induced β -cell apoptosis. Diabetes. 2001;50(suppl 1):S70–S76.
31. Arnette D, Gibson TB, Lawrence MC, et al. Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic β cells. J Biol Chem. 2003;278(35):32517–32525.
32. Lawrence MC, McGlynn K, Shao C, et al. Chromatin-bound mitogen- activated protein kinases transmit dynamic signals in transcription complexes in β -cells. Proc Natl Acad Sci USA. 2008;105(36): 13315–13320.
33. Ruff VA, Leach KL. Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. J Biol Chem. 1995;270(38): 22602–22607.
34. Qiu Y, Sharma A, Stein R. p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Mol Cell Biol. 1998;18(5):2957–2964.
35. Qiu Y, Guo M, Huang S, Stein R. Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E 47. Mol Cell Biol. 2002;22(2):412–420.
36. Mosley AL, Corbett JA, Ozcan S. Glucose regulation of insulin gene expression requires the recruitment of p300 by the β -cell-specific transcription factor Pdx-1. Mol Endocrinol. 2004;18(9):2279–2290.
37. Lawrence MC, Shao C, McGlynn K, Naziruddin B, Levy MF, Cobb MH. Multiple chromatin-bound protein kinases assemble factors that regulate insulin gene transcription. Proc Natl Acad Sci USA. 2009;106(52):22181–22186.
38. Ehses JA, Lacraz G, Giroix MH, et al. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci USA. 2009;106(33):13998–14003.
39. Butcher MJ, Hallinger D, Garcia E, et al. Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes. Diabetologia. 2014;57(3):491–501.
40. Potter KJ, Westwell-Roper CY, Klimek-Abercrombie AM, Warnock GL, Verchere CB. Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes? Diabetes. 2014;63(1): 12–19.
41. Sanna B, Bueno OF, Dai YS, Wilkins BJ, Molkentin JD. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Mol Cell Biol. 2005; 25(3):865–878.
42. Dougherty MK, Ritt DA, Zhou M, et al. KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. Mol Cell. 2009;34(6):652–662.